Probiotics interventions for hepatitis B liver cirrhosis patients with intestial microecological

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IIR-17011061

Enrollment

Unknown

Registered

2017-04-05

Start date

2017-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis B liver cirrhosis

Interventions

experimental group:Oral probiotic

The control group:General treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: No antibiotics and immunomodulators have been used in patients with hepatitis B cirrhosis.

Exclusion criteria

Exclusion criteria: Any antibiotic and immunomodulator in patients with hepatitis B cirrhosis.

Design outcomes

Primary

Measure	Time frame
Biochemical routine;Routine blood;Coagulation full;Blood ammonia;Allergic CRP;Calcitonin original;endotoxin;The abdomen colour to exceed;Hepatitis B virus DNA;	—

Secondary

Measure	Time frame
Upper abdominal enhancement CT;Upper abdomen enhances nuclear magnetic resonance;	—

Countries

China

Contacts

Public ContactDing Xiangchun

Ningxia Medical University General Hospital

13619511768@163.com+86 13619511768

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026